By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Coffee & Health

Intake of coffee, caffeine and other methylxanthines and risk of Type 1 vs Type II endometrial cancer

S Uccella et al, 2013
British Journal of Cancer, published online ahead of print
September 12, 2013


Coffee and other sources of methylxanthines and risk of Type I vs Type II endometrial cancer (EC) have not been evaluated previously.


Prospective cohort of 23 356 postmenopausal women with 471 Type I and 71 Type II EC cases.


Type I EC was statistically significantly associated with caffeinated (relative risk (RR)=0.65 for 4+ cups per day vs ≤1 cup per month: 95% confidence interval (CI): 0.47–0.89) but not decaffeinated (RR=0.76; 95% CI: 0.50–1.15) coffee intake; there were no associations with tea, cola or chocolate, or for Type II EC. The inverse association with caffeinated coffee intake was specific to women with a body mass index 30 = kg m-2 (RR=0.56; 95% CI: 0.36–0.89).


Coffee may protect against Type I EC in obese postmenopausal women.

More research

All research